- Home
- TC vs BNGO Comparison
TC vs BNGO Comparison
Compare TC & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TC | BNGO |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0M | 24.3M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TC | BNGO |
|---|---|---|
| Price | $7.57 | $1.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 14.4K | ★ 160.6K |
| Earning Date | 12-16-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,115,721.00 | ★ $28,720,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $1.45 |
| 52 Week High | $39.00 | $19.68 |
Technical Indicators
Market Signals| Indicator | TC | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 25.13 | 49.75 |
| Support Level | $6.70 | $1.47 |
| Resistance Level | $7.94 | $1.64 |
| Average True Range (ATR) | 1.10 | 0.06 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 14.67 | 78.79 |
Price Performance
Historical ComparisonAbout TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.